BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6646606)

  • 1. Improved tolerance of cytotoxic chemotherapy with lorazepam. A pilot study.
    Mughal TI
    Oncology; 1983; 40(6):392-4. PubMed ID: 6646606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy.
    Friedlander ML; Kearsley JH; Sims K; Coates A; Hedley D; Raghavan D; Fox RM; Tattersall MH
    Aust N Z J Med; 1983 Feb; 13(1):53-6. PubMed ID: 6136266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
    Ono A; Kishimoto K; Hasegawa D; Goldman RD; Kosaka Y
    Support Care Cancer; 2019 Mar; 27(3):895-899. PubMed ID: 30066198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorazepam as an adjunct to antiemetic therapy in patients receiving cytotoxic chemotherapy.
    Briceland LL
    Conn Med; 1987 Mar; 51(3):165-7. PubMed ID: 3568651
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
    Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiemetic prophylaxis of cancer chemotherapy-induced nausea and vomiting with cinnarizine and lorazepam.
    Wilder-Smith CH; Senn HJ
    Oncology; 1989; 46(3):169-72. PubMed ID: 2717127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
    Bilgrami S; Fallon BG
    Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorazepam for the control of chemotherapy-related nausea and vomiting in children.
    van Hoff J; Olszewski D
    J Pediatr; 1988 Jul; 113(1 Pt 1):146-9. PubMed ID: 3385522
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects.
    Laszlo J; Clark RA; Hanson DC; Tyson L; Crumpler L; Gralla R
    J Clin Oncol; 1985 Jun; 3(6):864-9. PubMed ID: 4040158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients.
    Scher CS; Amar D; McDowall RH; Barst SM
    Can J Anaesth; 1992 Feb; 39(2):170-2. PubMed ID: 1544199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
    Dix S; Cord M; Howard S; Coon J; Belt R; Geller R
    Bone Marrow Transplant; 1999 Sep; 24(5):561-6. PubMed ID: 10482943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total control of chemotherapy induced emesis.
    Helson L
    Anticancer Res; 1992; 12(6B):2243-4. PubMed ID: 1295471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.
    Bleicher J; Bhaskara A; Huyck T; Constantino S; Bardia A; Loprinzi CL; Silberstein PT
    J Support Oncol; 2008 Jan; 6(1):27-32. PubMed ID: 18257398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of chemotherapy-induced emesis highlighting the role of lorazepam as adjuvant therapy.
    Cooper R; Gent P
    Int J Palliat Nurs; 2002 Jul; 8(7):331-5. PubMed ID: 12165717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy.
    Falkson CI; Falkson HC
    Oncology; 1995; 52(5):427-31. PubMed ID: 7637962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.